Your browser doesn't support javascript.
loading
Piperine attenuates the cancerous activity response in Neuro-2a cell line
Pakistan Journal of Pharmaceutical Sciences. 2018; 31 (4 [Supp.]): 1529-1538
em Inglês | IMEMR | ID: emr-199545
ABSTRACT
Interactions of cancer cells with their microenvironment play a significant role in defining the severity of the disease. In search of novel compounds with anti-inflammatory and anticancerous capabilities, the effects of purified compound piperine were investigated in Neuro-2a cell line. The neuronal lineage of Neuro-2a cell line was confirmed by using antibody against Beta-III tubulin protein. The cells were treated with different concentrations of piperine [MuM 10, 50 and 100] for 48 hrs at 37 degree C. A dose of 100 MuM was selected that induces a 50% inhibition in the cell growth calculated by MTT and morphometery assays. The result shows that in the presence of piperine neurite outgrowth was decreased in a dose dependent manner. The gene expression of TN-C, TNfnD and TnfnC were significantly reduced whereas the expression intensities of TnfnA1, TnfnA2, CSPGs and Laminin were significantly elevated when compared to their respective untreated controls. Similarly proinflammatory marker COX-2 expression was significantly inhibited in the presence of piperine when compared to untreated controls. This is the first time we have illustrated that irrespective of increased expressions of CSPGs, a significant reduction in Tenascin-C and its TNfnD and TNfnC domains are necessary to inhibit the tumor progression. Taken together, the capabilities of piperine to induce an apoptosis by decreasing the neurite outgrowth, proliferation rate and expression of TN-C and COX-2 in Neuro-2a cell line confirmed for its anticancerous and anti-inflammatory potential
Buscar no Google
Índice: IMEMR (Mediterrâneo Oriental) Idioma: Inglês Revista: Pak. J. Pharm. Sci. Ano de publicação: 2018

Similares

MEDLINE

...
LILACS

LIS

Buscar no Google
Índice: IMEMR (Mediterrâneo Oriental) Idioma: Inglês Revista: Pak. J. Pharm. Sci. Ano de publicação: 2018